secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0000896264-24-000180
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q2 net sales $213M (-11% YoY), EPS $0.54 (-39%); cuts FY2024 guidance
---------------------------------------------------------------------------

- Diluted EPS $0.54 vs. $0.89 in Q2 2023; net sales $213M down 11% YoY to $238M.
- Active customers fell 4% YoY to 468,000; macro pressures and fewer promotions cited.
- FY24 outlook: net sales $850-880M (prev $850-920M), EPS $2.40-2.55 (prev $2.40-3.00).
- Operating margin revised to 8.0%-8.8%; effective tax rate raised to 43%-44%.
- Cash $332M, no debt; no share repurchases in Q2; $62M authorization remaining.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626424000180/0000896264-24-000180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626424000180/usna-20240723.htm
  HTML page:      https://secwatch.observer/filing/0000896264-24-000180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer